secwatch / observer
8-K filed December 23, 2022, 6:59 PM ET ticker EMED CIK 0001715819
leadership confidence high sentiment neutral materiality 0.30

Electromedical Technologies appoints Petar Gajic, Robert L. Hymers III to board

Electromedical Technologies, Inc

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Petar Gajic

Director
EMED · Electromedical Technologies, Inc
Effective
2022-12-20
Filed
December 23, 2022, 6:59 PM ET
On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.
Appointed

Robert L. Hymers, III

Director
EMED · Electromedical Technologies, Inc
Effective
2022-12-20
Filed
December 23, 2022, 6:59 PM ET
On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Petar Gajic was appointed as Director at Electromedical Technologies, Inc.

Action
appointed
Role
Director
Exact text from the filing
On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert L. Hymers, III was appointed as Director at Electromedical Technologies, Inc.

Action
appointed
Role
Director
Exact text from the filing
On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.
View on SEC.gov

Electromedical Technologies, Inc filing history →

Source: SEC EDGAR
accession 0001104659-22-129860
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.